Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Cash from Investing Activities (2017 - 2023)

Historic Cash from Investing Activities for Bio Green Med Solution (BGMS) over the last 14 years, with Q1 2023 value amounting to -$6000.0.

  • Bio Green Med Solution's Cash from Investing Activities fell 5000.0% to -$6000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was -$6000.0, marking a year-over-year increase of 1428.57%. This contributed to the annual value of -$6000.0 for FY2023, which is 1428.57% up from last year.
  • Per Bio Green Med Solution's latest filing, its Cash from Investing Activities stood at -$6000.0 for Q1 2023, which was down 5000.0% from -$3000.0 recorded in Q2 2022.
  • Over the past 5 years, Bio Green Med Solution's Cash from Investing Activities peaked at $62000.0 during Q2 2021, and registered a low of -$78000.0 during Q1 2021.
  • Its 5-year average for Cash from Investing Activities is -$9909.1, with a median of -$4000.0 in 2020.
  • As far as peak fluctuations go, Bio Green Med Solution's Cash from Investing Activities surged by 22272.73% in 2019, and later tumbled by 185000.0% in 2021.
  • Bio Green Med Solution's Cash from Investing Activities (Quarter) stood at $27000.0 in 2019, then crashed by 255.56% to -$42000.0 in 2020, then skyrocketed by 95.24% to -$2000.0 in 2021, then tumbled by 50.0% to -$3000.0 in 2022, then crashed by 100.0% to -$6000.0 in 2023.
  • Its Cash from Investing Activities was -$6000.0 in Q1 2023, compared to -$3000.0 in Q2 2022 and -$4000.0 in Q1 2022.